Haleon PLC American Depositary Shares (Each Representing Two Ordinary Shares) (HLN) closed at $9.14 on November 6, 2026, down 0.1% from the previous close, on volume of 17,209,969 shares (30-day average 20,489,837).
Data as of November 6, 2026.
6-Nov-2026
Haleon Held Amid Growth Misses and Margin Reset Risks as Price Target Is Cut to $320
TipRanks (Tue, 3-Nov 7:45 PM ET)
Goldman Sachs Sees Up to 250% Upside in These European Stocks, Adds Two New Picks
TipRanks (Tue, 3-Nov 7:08 AM ET)
Haleon Launches 'Haleon Health House,' a One-Day Interactive Wellness Pop-Up in Toronto
Globe Newswire (Mon, 19-Oct 7:00 AM ET)
Only Excedrin Brings Digital Pet Nostalgia Back with a Headache You Can't Ignore
PRNewswire (Mon, 12-Oct 6:21 AM ET)
Globe Newswire (Wed, 9-Sep 7:00 AM ET)
Business Wire (Thu, 27-Aug 8:00 AM ET)
PRNewswire (Wed, 19-Aug 5:00 AM ET)
Centrum Reframes Healthy Aging as a Proactive Practice for Adults 35 and Beyond
Business Wire (Thu, 13-Aug 3:00 PM ET)
Haleon plc: Cash tender offer for outstanding 2027 3.375% Fixed Rate Notes
PRNewswire (Tue, 11-Aug 8:49 AM ET)
Sensodyne’s ‘World’s Coldest Treat’ Pop-Up Highlights HLN’s Focus on Everyday Oral Health Solutions
Market Chameleon (Thu, 6-Aug 4:21 AM ET)
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
Haleon PLC American Depositary Shares (Each Representing Two Ordinary Shares) trades on the NYSE stock market under the symbol HLN.
As of November 6, 2026, HLN stock price declined to $9.14 with 17,209,969 million shares trading.
HLN has a beta of -0.06, meaning it tends to be less sensitive to market movements. HLN has a correlation of 0.00 to the broad based SPY ETF.
HLN has a market cap of $40.20 billion. This is considered a Large Cap stock.
In the last 3 years, HLN traded as high as $11.42 and as low as $7.89.
The top ETF exchange traded funds that HLN belongs to (by Net Assets): PPH, AVDE, AQEC, YLDE, QLTI.
HLN has underperformed the market in the last year with a price return of -0.8% while the SPY ETF gained +10.8%. HLN has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -8.2% and -11.0%, respectively, while the SPY returned -4.1% and -3.2%, respectively.
HLN support price is $8.99 and resistance is $9.31 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HLN shares will trade within this expected range on the day.
